Equity

Key Financial Ratios Home > Equity > Corporate Information > Key Financial Ratios

Jubilant Pharmova LtdIndustry : Pharmaceuticals - Indian - Bulk Drugs
BSE Code:530019 NSE Symbol: JUBLPHARMA P/E (TTM) :0
ISIN Demat:INE700A01033 Div & Yield %:0.73 EPS (TTM) :0
Book Value (RS) :146.9008161 Market Cap (Rs Cr.):10933.56 Face Value (RS) :1
    Change Company 
YearsMar 2023Mar 2022Mar 2021Mar 2020Mar 2019
Debt-Equity Ratio0.230.390.650.750.68
Long Term Debt-Equity Ratio0.190.360.460.440.33
Current Ratio1.590.681.150.990.83
Fixed Assets0.970.202.221.531.96
Inventory5.170.008.265.476.38
Debtors7.728.2712.746.937.06
Interest Cover Ratio5.283.693.683.192.42
PBIDTM (%)17.42135.7217.5317.2811.60
PBITM (%)12.08128.5913.8413.869.08
PBDTM (%)15.13100.8513.7712.947.85
CPM (%)11.5096.5811.6113.656.81
APATM (%)6.1689.467.9210.234.29
ROCE (%)4.286.2911.589.907.97
RONW (%)2.706.1211.0312.986.43

FOR GRIEVANCE MAIL TO invgrieviss@iseindia.com

BSE EQUITIES : INB011077733 | NSE F&O EQUITIES : INF231077737 | NSE CASH MARKET : INB231077737 | NSE CURRENCY DERIVATIVES : INE231077737 | MCX-SX : INE261077737

ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited], a wholly owned subsidiary of Inter-connected Stock Exchange of India Ltd. (ISE)

© 2013 ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited]. All rights reserved.

Designed, developed & powered by C-MOTS Infotech (ISO 9001:2008 certified)